COMP <GO>
NEOG vs IDXX // RETURN ON INVESTED CAPITAL (ROIC)
Neogen Corporation (NASDAQ) VS. IDEXX Laboratories Inc. (NASDAQ) • 15-METRIC TALLY: NEOG 1
— IDXX 9
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: IDXX
LAST: $11.82 (0.00%) • MKT CAP: $2.58B
roic
-0.60%
LAST: $671.64 (+21.85%) • MKT CAP: $43.42B
roic
29.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NEOG VS. IDXX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NEOG | IDXX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 46.90% | 61.80% | -14.90 | IDXX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -0.60% | 29.60% | -30.20 | IDXX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 31.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 3.11% | 2.33% | +0.78 | NEOG | /fcf-yield <GO> |
| Operating Margin | -2.50% | 31.60% | -34.10 | IDXX | /operating-margins <GO> |
| Net Profit Margin | -0.90% | 24.60% | -25.50 | IDXX | /net-margins <GO> |
| Revenue Growth (YoY) | -2.70% | 10.40% | -13.10 | IDXX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.45 | 20.99 | -19.54 | IDXX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | IDXX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.9 | 50.5 | -4.60 | IDXX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.89 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 39.8x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.58B | $43.42B | -$40.84B | IDXX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NEOG REV | IDXX REV | NEOG GROSS % | IDXX GROSS % | NEOG FCF | IDXX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $870.4M | $4.30B | 46.9% | 61.8% | $83.2M | $1.06B |
| FY 2024 | $894.7M | $3.90B | 47.1% | 61.0% | $58.2M | $808.1M |
| FY 2023 | $924.2M | $3.66B | — | — | $35.3M | $741.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NEOG // BETA —
IDXX // BETA 0.89